Recombinant interferon alfa ( DrugBank: Interferon alfa )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
26	HTLV-1関連脊髄症	1
28	全身性アミロイドーシス	2

26. HTLV-1関連脊髄症

臨床試験数 : 28 / 薬物数 : 48 - (DrugBank : 28) / 標的遺伝子数 : 38 - 標的パスウェイ数 : 127

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00041327 (ClinicalTrials.gov)	October 2002	8/7/2002	Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With ...	Phase II Trial Of Induction Therapy With EPOCH Chemotherapy And Maintenance Therapy With Combivir/In ...	Lymphoma	Biological: filgrastim;Biological: recombinant interferon alfa;Drug: Etoposide;Drug: cyclophosphamid ...	AIDS Malignancy Consortium	National Cancer Institute (NCI)	Completed	18 Years	120 Years	Both	19	Phase 2	United States

臨床試験数 : 261 / 薬物数 : 276 - (DrugBank : 81) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 178

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00007995 (ClinicalTrials.gov)	July 1999	6/1/2001	Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or ...	Phase 2 Study Of High Dose Chemotherapy Followed By Autologous Hematopoietic Stem Cell Support In Pa ...	Multiple Myeloma and Plasma Cell Neoplasm	Biological: filgrastim;Biological: recombinant interferon alfa;Biological: sargramostim;Drug: busulf ...	Herbert Irving Comprehensive Cancer Center	National Cancer Institute (NCI)	Completed	18 Years	N/A	Both	75	Phase 2	United States
2	NCT00002849 (ClinicalTrials.gov)	November 1996	1/11/1999	S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis	Phase II Study of Dexamethasone/Alpha-Interferon in AL Amyloidosis	Multiple Myeloma	Biological: recombinant interferon alfa;Drug: dexamethasone	Southwest Oncology Group	National Cancer Institute (NCI);Cancer and Leukemia Group B	Completed	18 Years	N/A	Both	93	Phase 2	United States